While reviewing the American College of Cardiology 2022 Scientific Sessions, Amun Saeed, MD, highlights the potential therapeutic advances presented by the results of three studies: APOLLO, PACMAN-AMI, and TRANSLATE-TIMI 70.
Each trial addressed a separate aspect of the role of lipids in atherosclerotic cardiovascular disease, and the outcomes of each offer a promise of new clinical benefits for patients burdened with lipid disorder.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: American College of Cardiology 2022: Reflections on Lipid Management - Medscape - Apr 27, 2022.
Comments